SCYNEXIS INC - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by SCYNEXIS, Inc. on May 1, 2020. The report addresses a Regulation FD disclosure regarding the filing of a Form S-3 registration statement.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, margin, or liquidity metrics. The only financial figure disclosed relates to a debt instrument:
- Convertible Debt: $10 million aggregate principal amount of 6.0% Convertible Senior Notes due 2026 issued to Puissance Life Science Opportunities Fund VI on April 9, 2020.
Material Changes
The material event reported is the filing of a Form S-3 registration statement to facilitate the resale of common stock by Puissance Life Science Opportunities Fund VI. These shares are issuable upon the conversion of the $10 million Notes. SCYNEXIS is not selling any shares under this registration and will not receive proceeds from the resale of converted shares.
Guidance, Outlook, and Risks
The filing contains no management guidance, financial outlook, or discussion of risks and contingencies beyond the mechanics of the registration statement. No unusual items were reported.
Investor Verification Checklist
- Verify the terms of the $10 million 6.0% Convertible Senior Notes due 2026 issued on April 9, 2020.
- Confirm the conversion price and potential dilution impact of the Notes on the existing share count.
- Review the preliminary prospectus filed with the Form S-3 for details on the resale mechanics.
- Check subsequent filings for any actual conversion of the Notes into common stock.